()
 
 

Overview

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive (hepatitis A), Bilive (combined hepatitis A and B) and Anflu (influenza). Sinovac is currently developing human vaccines against the H5N1 strain of pandemic influenza, Japanese encephalitis and SARS.


Contact Information

39 Shangdi Xi Road
Haidian District
Beijing, 100085

tel:
fax:
http://www.sinovac.com

,  



Investor Relations



tel:
fax:




Stock

Exchange: AMEX
Industry: Drug Manufacturers - Other
Market Cap: $164.4M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.